SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹-348 Cr | ₹4.33 Cr | ₹276 Cr |
What is the latest Net Current Assets ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹-348 Cr |
| Mar2024 | ₹4.33 Cr |
| Mar2023 | ₹276 Cr |
How is Net Current Assets of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹-348 Cr | Negative | |
| Mar2024 | ₹4.33 Cr | -98.43 | |
| Mar2023 | ₹276 Cr | - | |
Compare Net Current Assets of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹7,512.2 Cr | -2.7% | 4.4% | 43.6% | Stock Analytics | |
| SAGILITY | ₹18,453.8 Cr | -1.6% | -4.8% | 0.4% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹17,493.0 Cr | -2.3% | -5.8% | -31% | Stock Analytics | |
| PRIME FOCUS | ₹16,380.1 Cr | -6% | -12.7% | 81.8% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹15,153.7 Cr | -2.3% | -5.1% | 4.1% | Stock Analytics | |
| INDEGENE | ₹12,448.6 Cr | -4.5% | -0.6% | -10% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -2.7% |
4.4% |
43.6% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses